WO1999041354A1 - Protocol for simulated natural biofilm formation - Google Patents

Protocol for simulated natural biofilm formation Download PDF

Info

Publication number
WO1999041354A1
WO1999041354A1 PCT/US1999/003123 US9903123W WO9941354A1 WO 1999041354 A1 WO1999041354 A1 WO 1999041354A1 US 9903123 W US9903123 W US 9903123W WO 9941354 A1 WO9941354 A1 WO 9941354A1
Authority
WO
WIPO (PCT)
Prior art keywords
biofilm
accordance
slide
reservoir
protocol
Prior art date
Application number
PCT/US1999/003123
Other languages
French (fr)
Inventor
Shannon L. Bakich
Mark M. Gipp
Original Assignee
S.C. Johnson & Son, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S.C. Johnson & Son, Inc. filed Critical S.C. Johnson & Son, Inc.
Priority to DK99906994T priority Critical patent/DK1053299T3/en
Priority to AU26771/99A priority patent/AU2677199A/en
Priority to CA002321258A priority patent/CA2321258C/en
Priority to DE69900632T priority patent/DE69900632T2/en
Priority to EP99906994A priority patent/EP1053299B1/en
Priority to AT99906994T priority patent/ATE211165T1/en
Publication of WO1999041354A1 publication Critical patent/WO1999041354A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/02—Form or structure of the vessel
    • C12M23/04—Flat or tray type, drawers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M39/00—Means for cleaning the apparatus or avoiding unwanted deposits of microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/46—Means for regulation, monitoring, measurement or control, e.g. flow regulation of cellular or enzymatic activity or functionality, e.g. cell viability
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/97—Test strip or test slide

Definitions

  • This invention generally relates to methodology for production of experimental biofilm matrices on selected surfaces. More specifically this invention relates to the production of simulated natural bio films for testing the activities of formulated products for inhibition or removal of the simulated biofilms from a support surface. BACKGROUND ART
  • Biofilm science is reviewed in publications such as Food Reviews International, 8 (4), 573 (1992); Microbial Ecology in Health and Disease, 8, 305 (1995); Annu. Rev. Microbial, 49, 711 (1995); Applied and Environmental Microbiology, 4014 (Nov. 1996); and "Biofilms” by W. G. Characklis and K. C. Marshall (John Wiley & Sons, Inc., New York, 1989).
  • a biofilm consists of cells immobilized on a substratum and embedded in an organic polymer matrix of microbial origin.
  • a biofilm is a surface accumulation, which is not necessarily uniform in time or space.
  • a biofilm may be composed of a significant fraction of inorganic or abiotic substances held cohesively by the biotic matrix.
  • a biofilm is a protective matrix for bacteria, with the essential purpose of survival in an environment of limited nutrient supply.
  • Biofilms consist of both host microbes and their extracellular products, usually exopolysaccharides. Microbes have a tendency to form these protective exopolysaccharide matrices after they have adhered to a surface. The formation of biofilm complexes requires only humid conditions and/or water systems and contact with a support surface. With respect to nutrients, a nutrient deficiency in fact may increase the biofilm formation capacity of microbes, as reported in Adv. Appl. Microbiol., 29, 93 (1983). -2-
  • Biofilms generally can be produced by almost all microbes under suitable conditions.
  • the most common biofilm producers belong to the genera Pseudomonas, Enter obacter, Flavobacterium, Alcaligenes, Staphylococcus, and Bacillus.
  • biofilms can cause energy losses and blockages in condenser and heat exchange tubes, interfere with water and waste water systems, and form drag-inducing encrustations on ship hulls.
  • a biofilm formed by bacteria such as a Pseudomonas species can be the systemic causation of diseases of the lungs or the gastrointestinal and urinary tracts. Additionally, a biofilm formed by bacteria such as Staphylococcus species can be a serious contamination problem in foreign-body instruments such as cardiac pacemakers, catheters, prostheses, artificial valves, and the like. Dental plaque is also a typical form of biofilm.
  • biofilms One of the main purposes of natural biofilm formation is for the protection of the host microbes from a hostile environment. As a consequence, there is a combative interaction between microbes in biofilms and biocidal vehicles such as preservatives, disinfectants and antibiotics. Further, the sessile mode of bacterial growth in biofilms differs from that of the same bacteria species that are present as planktonic cells in a circulating aqueous medium which interfaces with the biofilm. Biofilms also act as a trap for nutrient acquisition, which is an important factor when bacteria grow on surfaces and the nutrient supply is oligotrophic.
  • biofilm formation Because of the manifold ramifications of biofilm formation, there is a serious commitment to biofilm research in a broad range of scientific investigations.
  • Methods of studying biofilm formation include microbiological, physical, and chemical methods. When microbes from extreme natural environments are cultured, standard plate counts usually do not provide accurate estimates. Thus, the classical evaluation methods relying on microbiological plating have questionable value with respect to the laboratory study of biofilms which are intended to achieve authentic correspondence with natural biofilms which exist in the biosphere.
  • formation of a natural type biofilm in the laboratory environment is difficult, mainly because there are no standardized methodologies currently available. -3-
  • One or more objects of the present invention are accomplished by the provision of a method for controlled biofilm formation in accordance with a monitored protocol which comprises (1) arranging at least one removable slide within the internal reservoir of a reactor; (2) introducing a bacterial inoculum and aqueous nutrient medium into the reservoir; (3) providing the aqueous suspension medium with agitation for an incubation period sufficient to initiate bacterial attachment to the slide surface; (4) draining the suspension medium from the reservoir; (5) recharging the reservoir with aqueous nutrient medium to maintain bacterial growth for an elapsed time period sufficient to establish a biofilm of prescribed thickness on the slide surface; and (6) retrieving the slide from the reservoir, and optionally determining the population of bacterial Colony Forming Units per square centimeter of the biofilm on the slide surface.
  • a suitable laboratory scale reactor can comprise an annular reactor which has dimensions between about 2-30 centimeters in diameter and 5-50 centimeters in height.
  • a preferred type of reactor is one constructed of polycarbonate, with a rotating inner drum which is adapted to secure stainless steel type retrievable slides.
  • this invention provides a method for controlled biofilm formation in accordance with a monitored protocol which comprises (1) arranging removable slides within the internal reservoir of a reactor; (2) introducing a bacterial inoculum and aqueous nutrient medium into the reservoir; (3) providing the aqueous suspension medium with agitation for an incubation period sufficient to initiate bacterial attachment to the slide surfaces; (4) draining the suspension medium from the reservoir; (5) recharging the reservoir with aqueous nutrient medium at least once every 24 hours of elapsed time period; (6) repeating the step (5) regimen for an extended period sufficient to establish a biofilm of prescribed thickness on the slide surfaces; and (7) retrieving the slides from the reservoir, and optionally determining the population of bacterial Colony Forming Units per square centimeter of the biofilm on the slide surfaces.
  • a standardized Mineral Salts nutrient medium can be employed for the biofilm bacterial growth cycles. Suitable nutrient media for biofilm formation are described in technical publications such as Biotechnol. Bioeng., 5 (5), 459 (1997); incorporated herein by reference.
  • a typical nutrient medium contains sources of carbon, nitrogen, phosphate and trace nutrients.
  • the bacterial inoculum is derived from a natural biofilm. This is illustrated by a bacterial inoculum which is extracted from a household drain biofilm.
  • the monitored protocol in the reactor is designed to provide essential correspondence with simulated household drain conditions, thereby promoting the formation of a simulated biofilm in the reactor which has close correspondence with a household drain natural biofilm.
  • simulated biofilm refers to a derivative biofilm which has essential phenotypic correspondence with the bacterial consortia of its sampled natural biofilm.
  • natural biofilm refers to a biospheric surface- mediated bacterial consortium which is in a dynamic relationship with environmental parameters. MODES OF CARRYING OUT THE INVENTION
  • the present invention methodology has particular advantage for the preparation of simulated biofilms which are a convenient and reliable vehicle for testing the activities of formulated products, where said products are intended for inhibition or removal of natural biofilms having a derivative relationship with the simulated biofilms respectively.
  • the present invention methodology can be illustrated by reference to a simulated household drain biofilm which is derived from an inoculum of a natural household drain biofilm.
  • the inoculum and aqueous nutrient medium are introduced into an annular reactor which holds a set of stainless steel slides.
  • the reactor contents are incubated for between about 4-60 hours at a temperature between about 15 ° -45 ° C.
  • the reactor reservoir is drained and recharged with aqueous nutrient medium at least once every 48 hours, over an elapsed time period of at least about 72 hours.
  • the reservoir is drained and recharged at least twice every 24 hours, over an elapsed time period between about 2-45 days.
  • Simulated biofilm growth on the slide surfaces in the annular reactor is continued until a desired biofilm thickness is achieved, e.g., between about 10-500 microns.
  • the biotic population in a simulated biofilm typically will be between about 10 5 -10 15 bacterial Colony Forming Units per square centimeter (CFU/cm 2 ) on the slide surfaces.
  • the methodology of the present invention has general utility for the production of simulated biofilms which are intended for application in a further protocol for testing the activity of an experimental product or a commercial product.
  • the further protocol can include testing the activity of products such as biocides and cleaners, and products for opening conduits which are clogged with biomass, and the like.
  • EXAMPLE I This Example illustrates invention methodology for growing a simulated biofilm, as derived from a household drain natural biofilm inoculum, in an annular reactor under simulated household drain conditions.
  • An annular reactor with a rotatable inner drum is utilized (Biosurface
  • the reactor has a 23 cm height and a 13 cm diameter, and is constructed of autoclavable polycarbonate.
  • the reactor is adapted to secure the 12 stainless steel slides which are employed in the protocol.
  • a biofilm sample is extracted from a household drain, and used as the protocol inoculum.
  • aqueous nutrient medium which has the following composition: 0.2% yeast extract 0.2% Trypticase soy broth 0.1% kaolin solution 7 g/L K 2 HPO 4
  • the reactor contents are incubated for two days at room temperature; (6) the reactor liquid volume is drained, and the reactor is refilled with nutrient medium and shaving residue;
  • step (6) drain and refill procedure is repeated two times per 24 hours to simulate household drain usage, and the procedure is continued for a time period between about 4-6 weeks sufficient to develop a 40-50 micron thick biofilm on the stainless steel slides (10 9 -10 12 Colony Forming Units per square centimeter);
  • biofilm-coated slides are utilized in a further protocol to test the activities of laboratory formulations and commercial products.
  • EXAMPLE II This Example illustrates a method for determining the Colony Forming Units per square centimeter (CFU/cm 2 ) on biofilm-coated slides.
  • a stainless slide retrieved from the annular reactor in Example I is placed in a beaker with 10 ml of PBS nutrient medium.
  • the slide is scraped from top to bottom using a sterile cell scraper to provide a biofilm sample.
  • the sample is homogenized one minute with a tissumizer operating at moderate speed.
  • One ml of the homogenized biofilm sample is diluted in 9 ml of PBS medium.
  • the resulting 10 ml sample is vortexed, and then the sample is diluted serially.
  • a 0.1 ml quantity of a diluted sample is plated on R2A agar. Each sample dilution is plated in triplicate.
  • the dilution sample on each plate is spread with a plate spreader, and the plates are incubated at room temperature for five days.
  • a plated sample which has approximately 30-300 colonies is counted.
  • the colony counts, dilution, and the scraped area of the slide is used to determine CFU/cm 2 . -8-
  • EXAMPLE III This Example illustrates a method for testing the activities of household drain care products on laboratory-grown biofilms which simulate natural household drain biofilms.
  • a sink and drain system is assembled from three 6" straight sections of 1.25"
  • the drain system is flushed with one gallon of water (38 ° C).
  • One biofilm-coated slide in accordance with the Example I protocol is secured to the top of the horizontal glass pipe section after the P-trap, and another biofilm- coated slide is secured to the bottom of the horizontal glass pipe section after the P-trap.
  • a household drain-care product is dispensed into the drain system, and the product is maintained in the drain system for 8 hours.
  • the drain system then is gently rinsed with one gallon of water (38 ° C).
  • the treated slides are removed and placed into wells of a slotted tray.
  • the slides are submerged in 5% sodium thiosulfate solution for two minutes, and then transferred to a second tray with deionized water.
  • the CFU/cm 2 are determined, and compared with the initial count of control samples.
  • the comparative data indicate that Formulation DC-X effectively treats a greater biofilm surface area than the PS Liquid Plumr product.
  • Formulation DC-X removes more biofilm than Plumr on the top slide in the drain system, as determined by the remaining CFU/cm 2 count on the slide. With respect to the bottom slide in the drain system, DC-X and Plumr are equally effective.
  • Top and bottom slides treated with DC-X have similar reduction in the amount of biofilm, while the top slide treated with Plumr has less reduction than the bottom slide treated with Plumr.
  • a method for producing a biofilm useful for testing cleaning products and other formulated products intended to inhibit, remove, or otherwise affect such films is useful, for example, in the development of commercial cleaning products.

Abstract

This invention provides a methodology for controlled biofilm formation in accordance with a monitored protocol. In a typical embodiment, a natural biofilm inoculum is used to form a simulated natural biofilm on retrievable slides in an annular reactor. The monitor protocol in the annular reactor subjects the bacterial consortia of the simulated natural biofilm to simulated environmental conditions. The invention simulated natural biofilm on a slide surface has utility for the testing of formulated product activity for inhibition or removal of the simulated natural biofilm, thereby providing a reliable indicator of the relative activity of the products under natural environmental conditions.

Description

-1-
PROTOCOL FOR SIMULATED NATURAL BIOFILM FORMATION
TECHNICAL FIELD
This invention generally relates to methodology for production of experimental biofilm matrices on selected surfaces. More specifically this invention relates to the production of simulated natural bio films for testing the activities of formulated products for inhibition or removal of the simulated biofilms from a support surface. BACKGROUND ART
Since 1943 a vast technical literature has developed in connection with advances in biofilm research. The understanding of biofilm processes has progressed rapidly in the last decade. One of the ultimate goals in studying biofilms is to evolve means for manipulating these processes for technological and ecological advantage. Biofilm science is reviewed in publications such as Food Reviews International, 8 (4), 573 (1992); Microbial Ecology in Health and Disease, 8, 305 (1995); Annu. Rev. Microbial, 49, 711 (1995); Applied and Environmental Microbiology, 4014 (Nov. 1996); and "Biofilms" by W. G. Characklis and K. C. Marshall (John Wiley & Sons, Inc., New York, 1989). As elaborated in the technical literature, a biofilm consists of cells immobilized on a substratum and embedded in an organic polymer matrix of microbial origin. A biofilm is a surface accumulation, which is not necessarily uniform in time or space. A biofilm may be composed of a significant fraction of inorganic or abiotic substances held cohesively by the biotic matrix. A biofilm is a protective matrix for bacteria, with the essential purpose of survival in an environment of limited nutrient supply.
Biofilms consist of both host microbes and their extracellular products, usually exopolysaccharides. Microbes have a tendency to form these protective exopolysaccharide matrices after they have adhered to a surface. The formation of biofilm complexes requires only humid conditions and/or water systems and contact with a support surface. With respect to nutrients, a nutrient deficiency in fact may increase the biofilm formation capacity of microbes, as reported in Adv. Appl. Microbiol., 29, 93 (1983). -2-
Biofilms generally can be produced by almost all microbes under suitable conditions. The most common biofilm producers belong to the genera Pseudomonas, Enter obacter, Flavobacterium, Alcaligenes, Staphylococcus, and Bacillus. There also are anaerobes that can construct corrosive biofilms. Besides causing problems in cleaning and hygiene, biofilms can cause energy losses and blockages in condenser and heat exchange tubes, interfere with water and waste water systems, and form drag-inducing encrustations on ship hulls. In the medical disciplines, a biofilm (referred to as "glycocalyx") formed by bacteria such as a Pseudomonas species can be the systemic causation of diseases of the lungs or the gastrointestinal and urinary tracts. Additionally, a biofilm formed by bacteria such as Staphylococcus species can be a serious contamination problem in foreign-body instruments such as cardiac pacemakers, catheters, prostheses, artificial valves, and the like. Dental plaque is also a typical form of biofilm.
One of the main purposes of natural biofilm formation is for the protection of the host microbes from a hostile environment. As a consequence, there is a combative interaction between microbes in biofilms and biocidal vehicles such as preservatives, disinfectants and antibiotics. Further, the sessile mode of bacterial growth in biofilms differs from that of the same bacteria species that are present as planktonic cells in a circulating aqueous medium which interfaces with the biofilm. Biofilms also act as a trap for nutrient acquisition, which is an important factor when bacteria grow on surfaces and the nutrient supply is oligotrophic.
Because of the manifold ramifications of biofilm formation, there is a serious commitment to biofilm research in a broad range of scientific investigations. Methods of studying biofilm formation include microbiological, physical, and chemical methods. When microbes from extreme natural environments are cultured, standard plate counts usually do not provide accurate estimates. Thus, the classical evaluation methods relying on microbiological plating have questionable value with respect to the laboratory study of biofilms which are intended to achieve authentic correspondence with natural biofilms which exist in the biosphere. In addition, formation of a natural type biofilm in the laboratory environment is difficult, mainly because there are no standardized methodologies currently available. -3-
There is increasing interest in the research and development of methodologies for the production and study of biofilms in a laboratory environment. Accordingly, it is an object of this invention to provide an improved method for the laboratory production of biofilms which simulate natural biofilms that grow under biospheric conditions. It is another object of this invention to provide a laboratory protocol for simulated natural biofilm production, in combination with a further protocol for testing the activities of formulated products for inhibition or removal of the simulated biofilms as a reliable indicator of the same activities under natural environmental conditions. Other objects and advantages of the present invention shall become apparent from the accompanying description and examples.
Publications of background interest with respect to the present invention include Wat. Res., 29 (8), 2006 (1995); J. Ind. Microbial, 15, 137 (1995); and references cited therein; incorporated herein by reference. DISCLOSURE OF INVENTION
One or more objects of the present invention are accomplished by the provision of a method for controlled biofilm formation in accordance with a monitored protocol which comprises (1) arranging at least one removable slide within the internal reservoir of a reactor; (2) introducing a bacterial inoculum and aqueous nutrient medium into the reservoir; (3) providing the aqueous suspension medium with agitation for an incubation period sufficient to initiate bacterial attachment to the slide surface; (4) draining the suspension medium from the reservoir; (5) recharging the reservoir with aqueous nutrient medium to maintain bacterial growth for an elapsed time period sufficient to establish a biofilm of prescribed thickness on the slide surface; and (6) retrieving the slide from the reservoir, and optionally determining the population of bacterial Colony Forming Units per square centimeter of the biofilm on the slide surface.
A suitable laboratory scale reactor can comprise an annular reactor which has dimensions between about 2-30 centimeters in diameter and 5-50 centimeters in height. A preferred type of reactor is one constructed of polycarbonate, with a rotating inner drum which is adapted to secure stainless steel type retrievable slides. Annular reactors -4-
.are commercially available products, such as the annular reactors sold by Biosurface Technologies, Corp., Bozeman, Montana.
In another embodiment this invention provides a method for controlled biofilm formation in accordance with a monitored protocol which comprises (1) arranging removable slides within the internal reservoir of a reactor; (2) introducing a bacterial inoculum and aqueous nutrient medium into the reservoir; (3) providing the aqueous suspension medium with agitation for an incubation period sufficient to initiate bacterial attachment to the slide surfaces; (4) draining the suspension medium from the reservoir; (5) recharging the reservoir with aqueous nutrient medium at least once every 24 hours of elapsed time period; (6) repeating the step (5) regimen for an extended period sufficient to establish a biofilm of prescribed thickness on the slide surfaces; and (7) retrieving the slides from the reservoir, and optionally determining the population of bacterial Colony Forming Units per square centimeter of the biofilm on the slide surfaces. A standardized Mineral Salts nutrient medium can be employed for the biofilm bacterial growth cycles. Suitable nutrient media for biofilm formation are described in technical publications such as Biotechnol. Bioeng., 5 (5), 459 (1997); incorporated herein by reference. A typical nutrient medium contains sources of carbon, nitrogen, phosphate and trace nutrients. In a preferred embodiment, the bacterial inoculum is derived from a natural biofilm. This is illustrated by a bacterial inoculum which is extracted from a household drain biofilm. The monitored protocol in the reactor is designed to provide essential correspondence with simulated household drain conditions, thereby promoting the formation of a simulated biofilm in the reactor which has close correspondence with a household drain natural biofilm.
The term "simulated biofilm" as employed herein refers to a derivative biofilm which has essential phenotypic correspondence with the bacterial consortia of its sampled natural biofilm.
The term "natural biofilm" as employed herein refers to a biospheric surface- mediated bacterial consortium which is in a dynamic relationship with environmental parameters. MODES OF CARRYING OUT THE INVENTION The present invention methodology has particular advantage for the preparation of simulated biofilms which are a convenient and reliable vehicle for testing the activities of formulated products, where said products are intended for inhibition or removal of natural biofilms having a derivative relationship with the simulated biofilms respectively.
The present invention methodology can be illustrated by reference to a simulated household drain biofilm which is derived from an inoculum of a natural household drain biofilm.
In practice, the inoculum and aqueous nutrient medium are introduced into an annular reactor which holds a set of stainless steel slides. The reactor contents are incubated for between about 4-60 hours at a temperature between about 15 ° -45 ° C.
The reactor reservoir is drained and recharged with aqueous nutrient medium at least once every 48 hours, over an elapsed time period of at least about 72 hours.
Preferably, the reservoir is drained and recharged at least twice every 24 hours, over an elapsed time period between about 2-45 days.
Simulated biofilm growth on the slide surfaces in the annular reactor is continued until a desired biofilm thickness is achieved, e.g., between about 10-500 microns. The biotic population in a simulated biofilm typically will be between about 105-1015 bacterial Colony Forming Units per square centimeter (CFU/cm2) on the slide surfaces.
The methodology of the present invention has general utility for the production of simulated biofilms which are intended for application in a further protocol for testing the activity of an experimental product or a commercial product. The further protocol can include testing the activity of products such as biocides and cleaners, and products for opening conduits which are clogged with biomass, and the like.
The following examples are further illustrative of this present invention. The components and specific ingredients are presented as being typical, and various modifications can be derived in view of the foregoing disclosure within the scope of the invention. -6-
EXAMPLE I This Example illustrates invention methodology for growing a simulated biofilm, as derived from a household drain natural biofilm inoculum, in an annular reactor under simulated household drain conditions. An annular reactor with a rotatable inner drum is utilized (Biosurface
Technologies, Corp.; Bozeman, Montana). The reactor has a 23 cm height and a 13 cm diameter, and is constructed of autoclavable polycarbonate. The reactor is adapted to secure the 12 stainless steel slides which are employed in the protocol.
A biofilm sample is extracted from a household drain, and used as the protocol inoculum.
An aqueous nutrient medium is employed which has the following composition: 0.2% yeast extract 0.2% Trypticase soy broth 0.1% kaolin solution 7 g/L K2HPO4
3 g/L KH2PO4 l g/L (NH4)2 S04 0.1 g/L Mg SO4-»7 H2O warm water (28 ° -32 ° C) A sample of men's shaving residue is added to the reactor about every 24 hours with the nutrient medium. The residue contains EDGE® shaving cream, water, hair, and skin cells.
The protocol is conducted in the following manner:
(1) a loop of homogenized household drain biofilm is suspended in each of two flasks (100 ml of Trypticase soy broth respectively), and incubated for two days at
37 ° C in a shaking incubator;
(2) one ml of suspended bacteria from each flask is inoculated into a second flask (100 ml of Trypticase soy broth), and incubated with agitation for two days at 37 °C; (3) the suspension contents of one of the two flasks is charged to the annular reactor; -7-
(4) nutrient medium .and warm water (about 800 ml) are added to the annular reactor, which submerges 12 removable stainless steel slides that are secured to the inner drum surface, and the rotation of the inner drum is commenced;
(5) the reactor contents are incubated for two days at room temperature; (6) the reactor liquid volume is drained, and the reactor is refilled with nutrient medium and shaving residue;
(7) the step (6) drain and refill procedure is repeated two times per 24 hours to simulate household drain usage, and the procedure is continued for a time period between about 4-6 weeks sufficient to develop a 40-50 micron thick biofilm on the stainless steel slides (109-1012 Colony Forming Units per square centimeter);
(8) the stainless steel slides are retrieved, which have an attached biofilm with a bacterial community that has prototypic correspondence with the environmental consortia of the originally sampled natural household drain biofilm; and
(9) the biofilm-coated slides are utilized in a further protocol to test the activities of laboratory formulations and commercial products.
EXAMPLE II This Example illustrates a method for determining the Colony Forming Units per square centimeter (CFU/cm2) on biofilm-coated slides.
A stainless slide retrieved from the annular reactor in Example I is placed in a beaker with 10 ml of PBS nutrient medium. The slide is scraped from top to bottom using a sterile cell scraper to provide a biofilm sample. The sample is homogenized one minute with a tissumizer operating at moderate speed.
One ml of the homogenized biofilm sample is diluted in 9 ml of PBS medium. The resulting 10 ml sample is vortexed, and then the sample is diluted serially. A 0.1 ml quantity of a diluted sample is plated on R2A agar. Each sample dilution is plated in triplicate.
The dilution sample on each plate is spread with a plate spreader, and the plates are incubated at room temperature for five days.
A plated sample which has approximately 30-300 colonies is counted. The colony counts, dilution, and the scraped area of the slide is used to determine CFU/cm2. -8-
EXAMPLE III This Example illustrates a method for testing the activities of household drain care products on laboratory-grown biofilms which simulate natural household drain biofilms. A sink and drain system is assembled from three 6" straight sections of 1.25"
(I.D.) glass pipe, one 1.25" (I.D.) glass P-trap, and one 1.25 (I.D.) glass down-pipe section.
The drain system is flushed with one gallon of water (38 ° C). One biofilm-coated slide in accordance with the Example I protocol is secured to the top of the horizontal glass pipe section after the P-trap, and another biofilm- coated slide is secured to the bottom of the horizontal glass pipe section after the P-trap.
A household drain-care product is dispensed into the drain system, and the product is maintained in the drain system for 8 hours. The drain system then is gently rinsed with one gallon of water (38 ° C). The treated slides are removed and placed into wells of a slotted tray. The slides are submerged in 5% sodium thiosulfate solution for two minutes, and then transferred to a second tray with deionized water. The CFU/cm2 are determined, and compared with the initial count of control samples.
Following the above-described procedures, the activity of an experimental drain-care product, Formulation DC-X, is tested in comparison with a commercial drain-care product, PS Liquid Plumr®. The results of the comparative test are summarized in TABLES I-II.
TABLE I Treatment Last Square Mean (LOG CFU*) Control 9.00 A
Plumr (top slide) 7.72 B
DC-X (top slide) 4.43 C
DC-X (bottom slide) 3.76 Cd
Plumr (bottom slide) 3.68 Cd *ABC/abcd: Means with the same letter are not significantly different at
95/90% confidence level. -9-
TABLE II Test vs. Control Difference (Log CFU
Difference (prob)
DC-X DC-X Plumr Plumr
Top Bottom Top. Bottom
Control 4.66 5.24 (0.1) 1.28 (.10) 5.32 (.01)
DC-X Top Slide .58 (.10) 3.38 (.10) .67 (.06) DC-X Bottom Slide 3.96 (.01) .08 (nsd) Plumr Top Slide
Figure imgf000011_0001
4.05 (.01)
The comparative data indicate that Formulation DC-X effectively treats a greater biofilm surface area than the PS Liquid Plumr product. Formulation DC-X removes more biofilm than Plumr on the top slide in the drain system, as determined by the remaining CFU/cm2 count on the slide. With respect to the bottom slide in the drain system, DC-X and Plumr are equally effective.
Top and bottom slides treated with DC-X have similar reduction in the amount of biofilm, while the top slide treated with Plumr has less reduction than the bottom slide treated with Plumr.
The differences indicated by the comparative data are statistically significant (95% confidence level), and microbiologically significant. Specifically, the differences observed are greater than a 2 log reduction in the amount of biofilm, which is significant in terms of microbiological observations in the biospheric environment. INDUSTRIAL APPLICABILITY
A method is disclosed for producing a biofilm useful for testing cleaning products and other formulated products intended to inhibit, remove, or otherwise affect such films. This is useful, for example, in the development of commercial cleaning products.

Claims

-10- WHAT I CLAIM IS:
1. A method for controlled biofilm formation in accordance with a monitored protocol which comprises (1) arranging at least one removable slide within the internal reservoir of a reactor; (2) introducing a bacterial inoculum and aqueous nutrient medium into the reservoir; (3) providing the aqueous suspension medium with agitation for an incubation period sufficient to initiate bacterial attachment to the slide surface; (4) draining the suspension medium from the reservoir; (5) recharging the reservoir with aqueous nutrient medium to maintain bacterial growth for an elapsed time period sufficient to establish a biofilm of prescribed thickness on the slide surface; and
(6) retrieving the slide from the reservoir, and optionally determining the population of bacterial Colony Forming Units per square centimeter of the biofilm on the slide surface.
2. A method in accordance with Claim 1 wherein the reactor is annular and has dimensions between about 2-30 centimeters in diameter and 5-50 centimeters in height.
3. A method in accordance with Claim 1 wherein multiple stainless steel slides are arranged in the reservoir in step (1).
4. A method in accordance with Claim 1 wherein the bacterial inoculum is derived from a natural biofilm.
5. A method in accordance with Claim 1 wherein the bacterial inoculum is derived from a household drain biofilm, and the monitored protocol in the reactor corresponds to simulated household drain conditions.
6. A method in accordance with Claim 1 wherein the aqueous nutrient medium comprises yeast, peptone and mineral salt ingredients.
7. A method in accordance with Claim 1 wherein the step (3) incubation is for a period between about 40-60 hours at a temperature between about 15 ° -45 ° C.
8. A method in accordance with Claim 1 wherein the reactor reservoir in step (5) is drained and recharged with aqueous nutrient medium at least once every 48 hours of elapsed time period.
9. A method in accordance with Claim 1 wherein the step (5) elapsed time period is at least about 72 hours. -11-
10. A method in accordance with Claim 1 wherein the established biofilm in step (5) has a thickness between about 10-500 microns on the slide surfaces.
11. A method in accordance with Claim 1 wherein the established biofilm in step (5) has a population between about 105-1015 bacterial Colony Forming Units per square centimeter on the slide surfaces.
12. A method in accordance with Claim 1 wherein the biofilm which is coated on the slide surfaces is a simulated natural biofilm.
13. A method in accordance with Claim 1 wherein the biofilm-coated slide is utilized in a further protocol for testing the activity of a product.
14. A method in accordance with Claim 1 wherein the biofilm-coated slide is utilized in a further protocol for testing the activity of a biocide product.
15. A method in accordance with Claim 1 wherein the biofilm-coated slide is utilized in a further protocol for testing the activity of a cleaning product.
16. A method in accordance with Claim 1 wherein the biofilm-coated slide is utilized in a further protocol for testing the activity of a product for opening conduits which are clogged with biomass.
17. A method for controlled biofilm formation in accordance with a monitored protocol which comprises (1) arranging removable slides within the internal reservoir of a reactor; (2) introducing a bacterial inoculum and aqueous nutrient medium into the reservoir; (3) providing the aqueous suspension medium with agitation for an incubation period sufficient to initiate bacterial attachment to the slide surfaces; (4) draining the suspension medium from the reservoir; (5) recharging the reservoir with aqueous nutrient medium at least once every 24 hours of elapsed time period; (6) repeating the step (5) regimen for an extended period sufficient to establish a biofilm of prescribed thickness on the slide surfaces; and (7) retrieving the slides from the reservoir, and optionally determining the population of bacterial Colony Forming Units per square centimeter of the biofilm on the slide surfaces.
18. A method in accordance with Claim 17 wherein the bacterial inoculum is derived from a natural biofilm.
19. A method in accordance with Claim 17 wherein the bacterial inoculum is derived from a household drain biofilm, and the monitored protocol in the reactor corresponds to simulated household drain conditions. -12-
20. A method in accordance with Claim 17 wherein the reservoir in step (5) is drained and recharged with aqueous nutrient medium at least twice every 24 hours, over an elapsed time period between about 2-45 days.
21. A method in accordance with Claim 17 wherein the biofilm-coated slide is utilized in a further protocol for testing the activity of a product.
22. A method in accordance with Claim 17 wherein the biofilm-coated slide is utilized in a further protocol for testing the activity of a biocide product.
23. A method in accordance with Claim 17 wherein the biofilm-coated slide is utilized in a further protocol for testing the activity of a cleaning product.
24. A method in accordance with Claim 17 wherein the biofilm-coated slide is utilized in a further protocol for testing the activity of a product for opening conduits which are clogged with biomass.
25. A biofilm-coated slide produced in accordance with the method of
Claim 1.
26. A biofilm-coated slide produced in accordance with the method of
Claim 1, wherein the biofilm is a simulated natural biofilm.
27. A biofilm-coated slide produced in accordance with the method of Claim 17.
28. A biofilm-coated slide produced in accordance with the method of Claim 17, wherein the biofilm is a simulated natural biofilm.
PCT/US1999/003123 1998-02-13 1999-02-12 Protocol for simulated natural biofilm formation WO1999041354A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
DK99906994T DK1053299T3 (en) 1998-02-13 1999-02-12 Protocol for forming a simulated natural biofilm
AU26771/99A AU2677199A (en) 1998-02-13 1999-02-12 Protocol for simulated natural biofilm formation
CA002321258A CA2321258C (en) 1998-02-13 1999-02-12 Protocol for simulated natural biofilm formation
DE69900632T DE69900632T2 (en) 1998-02-13 1999-02-12 PROTOCOL FOR THE PRODUCTION OF A SIMULATED, NATURAL ORGANIC SURFACE
EP99906994A EP1053299B1 (en) 1998-02-13 1999-02-12 Protocol for simulated natural biofilm formation
AT99906994T ATE211165T1 (en) 1998-02-13 1999-02-12 PROTOCOL FOR PRODUCING A SIMULATED NATURAL BIOLOGICAL COVER

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/023,520 US5928889A (en) 1998-02-13 1998-02-13 Protocol for simulated natural biofilm formation
US09/023,520 1998-02-13

Publications (1)

Publication Number Publication Date
WO1999041354A1 true WO1999041354A1 (en) 1999-08-19

Family

ID=21815603

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/003123 WO1999041354A1 (en) 1998-02-13 1999-02-12 Protocol for simulated natural biofilm formation

Country Status (10)

Country Link
US (1) US5928889A (en)
EP (1) EP1053299B1 (en)
AT (1) ATE211165T1 (en)
AU (1) AU2677199A (en)
CA (1) CA2321258C (en)
DE (1) DE69900632T2 (en)
DK (1) DK1053299T3 (en)
ES (1) ES2165228T3 (en)
PT (1) PT1053299E (en)
WO (1) WO1999041354A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2229959A2 (en) 2009-03-18 2010-09-22 EMPA Eidgenössische Materialprüfungs- und Forschungsanstalt Standarized production of mature biofilms
EP3027727A4 (en) * 2013-07-29 2017-03-08 UTI Limited Partnership Annular culture dish
EP3647434A1 (en) 2018-10-30 2020-05-06 INDIAN OIL CORPORATION Ltd. Engineered electrode for electrobiocatalysis and process to construct the same

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6599714B1 (en) 1996-03-13 2003-07-29 University Technologies International Inc. Method of growing and analyzing a biofilm
US20060166358A1 (en) * 1997-03-12 2006-07-27 University Technologies International, Inc. Biofilm incubation
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
US6207405B1 (en) * 1998-06-29 2001-03-27 S. C. Johnson & Son, Inc. Pilot drain system for rapid biofilm formation
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US6750229B2 (en) 1998-07-06 2004-06-15 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin pigmentation
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
DE19931276C2 (en) * 1999-07-07 2002-10-24 Hans-Martin Seipp Process for the production of specimens with biofilm loading and process for the quantification of the loading of test specimens with biofilm as well as the use of the test specimens created with the production process
US7985404B1 (en) 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
US7309688B2 (en) 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
GB0004686D0 (en) * 2000-02-28 2000-04-19 Aventis Pharma Ltd Chemical compounds
US6599696B2 (en) 2000-04-17 2003-07-29 University Technologies International, Inc. Effects of materials and surface coatings on encrustation and biofilm formation
US20030032079A1 (en) * 2000-04-17 2003-02-13 Howard Ceri Apparatus and method for testing effects of materials and surface coating on the formation of biofilms
US6596505B2 (en) * 2000-04-17 2003-07-22 University Technologies International, Inc. Apparatus and methods for testing effects of materials and surface coatings on the formation of biofilms
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
US6555143B2 (en) 2001-02-28 2003-04-29 Johnson & Johnson Consumer Products, Inc. Legume products
US6793880B2 (en) * 2001-07-13 2004-09-21 Minntech Corporation Apparatus and method for monitoring biofilm cleaning efficacy
JP4890761B2 (en) 2002-07-19 2012-03-07 バクスター・インターナショナル・インコーポレイテッド System and method for performing peritoneal dialysis
DE102005014805B4 (en) * 2005-03-31 2012-12-06 Bayerische Motoren Werke Aktiengesellschaft Method for determining the growth of environmental germs
DE102006061746B3 (en) * 2006-12-21 2008-05-15 Mikrobiologisch-Analytisches Labor Gmbh Material properties detection or reflection method for biosensor, involves accelerating biological or biochemical processes so that specific acceleration and/or reciprocal effect between environment and material parameters are enabled
US7892332B2 (en) * 2007-10-01 2011-02-22 Baxter International Inc. Dialysis systems having air traps with internal structures to enhance air removal
US7871462B2 (en) * 2007-10-01 2011-01-18 Baxter International Inc. Dialysis systems having air separation chambers with internal structures to enhance air removal
US8444587B2 (en) 2007-10-01 2013-05-21 Baxter International Inc. Fluid and air handling in blood and dialysis circuits
US7892331B2 (en) * 2007-10-01 2011-02-22 Baxter International Inc. Dialysis systems having air separation chambers with internal structures to enhance air removal
US8123947B2 (en) 2007-10-22 2012-02-28 Baxter International Inc. Priming and air removal systems and methods for dialysis
US8114276B2 (en) 2007-10-24 2012-02-14 Baxter International Inc. Personal hemodialysis system
US8057679B2 (en) 2008-07-09 2011-11-15 Baxter International Inc. Dialysis system having trending and alert generation
US8382711B2 (en) 2010-12-29 2013-02-26 Baxter International Inc. Intravenous pumping air management systems and methods
US9486590B2 (en) 2014-09-29 2016-11-08 Fenwal, Inc. Automatic purging of air from a fluid processing system
WO2016207206A1 (en) 2015-06-25 2016-12-29 Gambro Lundia Ab Medical device system and method having a distributed database
US10625009B2 (en) 2016-02-17 2020-04-21 Baxter International Inc. Airtrap, system and method for removing microbubbles from a fluid stream
KR102476516B1 (en) 2016-12-21 2022-12-09 감브로 룬디아 아베 A medical device system that includes an information technology infrastructure with secure cluster domains supporting external domains.

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993001497A2 (en) * 1991-07-11 1993-01-21 Kiwa N.V. Monitor for growth and deposit
DE8908583U1 (en) * 1989-07-14 1993-08-05 Minuth, Will, Prof. Dr., 93077 Bad Abbach, De
EP0557041A1 (en) * 1992-02-16 1993-08-25 Benjamin Alspector Multi-functional device and method for detecting presence and extent of micro-organisms in a liquid sample or on a solid surface
US5403742A (en) * 1993-09-01 1995-04-04 Ramot University Authority Ltd. Bioreactor for production of products with immobilized biofilm
WO1995027039A1 (en) * 1994-03-31 1995-10-12 Kemira Chemicals Oy Biofilm device for the monitoring of microbial disturbances in industrial process waters
EP0747475A2 (en) * 1995-06-06 1996-12-11 Becton, Dickinson and Company Culture slide assembly
US5595893A (en) * 1992-06-19 1997-01-21 Iowa State University Research Foundation, Inc. Immobilization of microorganisms on a support made of synthetic polymer and plant material
US5650325A (en) * 1990-11-29 1997-07-22 Spielmann; Richard Apparatus having a rotatable stack of parallel trays with culturing surfaces on opposite sides for liquid/gas exchange
WO1997033972A1 (en) * 1996-03-13 1997-09-18 University Technologies International Inc. Biofilm incubation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3198005A (en) * 1962-01-08 1965-08-03 Nalco Chemical Co Multi-panel slime accumulator
US4631961A (en) * 1985-12-31 1986-12-30 Philadelphia Suburban Water Company Sampling device for determining conditions on the interior surface of a water main
US4945758A (en) * 1987-05-28 1990-08-07 Arabian American Oil Company Method and apparatus for monitoring the interior surface of a pipeline
US5349874A (en) * 1988-02-04 1994-09-27 Houseman Limited Method for microbiological monitoring
US5049492A (en) * 1990-03-14 1991-09-17 The United States Of America As Represented By The United States National Aeronautics And Space Administration Biofilm monitoring coupon system and method of use
US5246560A (en) * 1991-10-04 1993-09-21 Electric Power Research Institute, Inc. Apparatus for monitoring biofilm activity
CA2133265C (en) * 1994-09-29 2002-01-08 Serge R. Guiot Anaerobic and aerobic integrated system for biotreatment of toxic wastes (canoxis)
US5605836A (en) * 1995-06-13 1997-02-25 Chen; Chin-Yu Modular method and device for the evaluation of the ability of biocide to penetrate biofilm
US5709546A (en) * 1996-11-27 1998-01-20 Waggoner; Mark B. Water sanitizing system and process

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE8908583U1 (en) * 1989-07-14 1993-08-05 Minuth, Will, Prof. Dr., 93077 Bad Abbach, De
US5650325A (en) * 1990-11-29 1997-07-22 Spielmann; Richard Apparatus having a rotatable stack of parallel trays with culturing surfaces on opposite sides for liquid/gas exchange
WO1993001497A2 (en) * 1991-07-11 1993-01-21 Kiwa N.V. Monitor for growth and deposit
EP0557041A1 (en) * 1992-02-16 1993-08-25 Benjamin Alspector Multi-functional device and method for detecting presence and extent of micro-organisms in a liquid sample or on a solid surface
US5595893A (en) * 1992-06-19 1997-01-21 Iowa State University Research Foundation, Inc. Immobilization of microorganisms on a support made of synthetic polymer and plant material
US5403742A (en) * 1993-09-01 1995-04-04 Ramot University Authority Ltd. Bioreactor for production of products with immobilized biofilm
WO1995027039A1 (en) * 1994-03-31 1995-10-12 Kemira Chemicals Oy Biofilm device for the monitoring of microbial disturbances in industrial process waters
EP0747475A2 (en) * 1995-06-06 1996-12-11 Becton, Dickinson and Company Culture slide assembly
WO1997033972A1 (en) * 1996-03-13 1997-09-18 University Technologies International Inc. Biofilm incubation

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2229959A2 (en) 2009-03-18 2010-09-22 EMPA Eidgenössische Materialprüfungs- und Forschungsanstalt Standarized production of mature biofilms
EP3027727A4 (en) * 2013-07-29 2017-03-08 UTI Limited Partnership Annular culture dish
EP3647434A1 (en) 2018-10-30 2020-05-06 INDIAN OIL CORPORATION Ltd. Engineered electrode for electrobiocatalysis and process to construct the same

Also Published As

Publication number Publication date
DE69900632T2 (en) 2002-06-13
CA2321258C (en) 2005-02-08
EP1053299B1 (en) 2001-12-19
PT1053299E (en) 2002-05-31
AU2677199A (en) 1999-08-30
ATE211165T1 (en) 2002-01-15
DK1053299T3 (en) 2002-01-28
CA2321258A1 (en) 1999-08-19
ES2165228T3 (en) 2002-03-01
DE69900632D1 (en) 2002-01-31
EP1053299A1 (en) 2000-11-22
US5928889A (en) 1999-07-27

Similar Documents

Publication Publication Date Title
US5928889A (en) Protocol for simulated natural biofilm formation
Peters et al. A constant-depth laboratory model film fermenter
Exterkate et al. Different response to amine fluoride by Streptococcus mutans and polymicrobial biofilms in a novel high-throughput active attachment model
Vital et al. Growth of Vibrio cholerae O1 Ogawa Eltor in freshwater
Vinod Kumar et al. Coexistence and survival of pathogenic leptospires by formation of biofilm with Azospirillum
Jain et al. Isolation and characterization of biofilm-forming bacteria and associated extracellular polymeric substances from oral cavity
Kinniment et al. Measurements of the distribution of adenylate concentrations and adenylate energy charge across Pseudomonas aeruginosa biofilms
Jackson et al. Growing reproducible biofilms with respect to structure and viable cell counts
Fletcher Bacterial biofilms and biofouling
Meyer-Reil Bacterial growth rates and biomass production
Johnston et al. Disinfection tests with intact biofilms: combined use of the Modified Robbins Device with impedance detection
Maruthamuthu et al. Electrochemical behaviour of microbes on orthodontic wires
Jamieson et al. Coordinated surface activities in Variovorax paradoxus EPS
JP5367967B2 (en) Mold treating agent and mold treating method
Rosa et al. Adjusting culture conditions to isolate thraustochytrids from temperate and cold environments in southern Argentina
Dibdin et al. [23] Steady-state biofilm: Practical and theoretical models
Keevil [8] Continuous culture models to study pathogens in Biofilms
EP0969085B1 (en) Pilot drain system for rapid biofilm formation
La Scola et al. A novel alpha-Proteobacterium, Nordella oligomobilis gen. nov., sp. nov., isolated by using amoebal co-cultures
Janssen New cultivation strategies for terrestrial microorganisms
Moldoveanu Environmental factors influences on bacterial biofilms formation.
CN111621442A (en) Bacillus pumilus, preparation, composition and application
Gaju et al. Distribution of predatory bacteria that attack Chromatiaceae in a sulfurous lake
JP3174518B2 (en) Simple diagnostic method for biological treatment of sewage
Bernardi et al. Application of a Novel Tongue Resin Replication System for in vitro Biofilm Studies

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU BR CA JP NZ PL

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2321258

Country of ref document: CA

Ref country code: CA

Ref document number: 2321258

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1999906994

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999906994

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1999906994

Country of ref document: EP